During the past decade, Centro de Cancer Pontificie Universidad Catolica de Chile conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Centro de Cancer Pontificie Universidad Catolica de Chile" are "Cancer" (1 trials), "Influenza" (1 trials), "Triple Negative Breast Cancer" (1 trials) and "Triple-Negative Breast Cancer" (1 trials). Many other conditions were trialed in "Centro de Cancer Pontificie Universidad Catolica de Chile" in a lesser frequency.

Most popular intervention types in "Centro de Cancer Pontificie Universidad Catolica de Chile" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (2 trials), "Nab-Paclitaxel" (2 trials), "Placebo" (2 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials) and "Baloxavir Marboxil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centro de Cancer Pontificie Universidad Catolica de Chile" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Centro de Cancer Pontificie Universidad Catolica de Chile". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Centro de Cancer Pontificie Universidad Catolica de Chile, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Centro de Cancer Pontificie Universidad Catolica de Chile, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".